1. Home
  2. FFIC vs FATE Comparison

FFIC vs FATE Comparison

Compare FFIC & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFIC
  • FATE
  • Stock Information
  • Founded
  • FFIC 1929
  • FATE 2007
  • Country
  • FFIC United States
  • FATE United States
  • Employees
  • FFIC N/A
  • FATE N/A
  • Industry
  • FFIC Major Banks
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FFIC Finance
  • FATE Health Care
  • Exchange
  • FFIC Nasdaq
  • FATE Nasdaq
  • Market Cap
  • FFIC 454.6M
  • FATE 406.5M
  • IPO Year
  • FFIC 1995
  • FATE 2013
  • Fundamental
  • Price
  • FFIC $17.42
  • FATE $2.07
  • Analyst Decision
  • FFIC Hold
  • FATE Hold
  • Analyst Count
  • FFIC 4
  • FATE 10
  • Target Price
  • FFIC $15.50
  • FATE $6.75
  • AVG Volume (30 Days)
  • FFIC 190.7K
  • FATE 3.0M
  • Earning Date
  • FFIC 10-24-2024
  • FATE 11-12-2024
  • Dividend Yield
  • FFIC 5.08%
  • FATE N/A
  • EPS Growth
  • FFIC N/A
  • FATE N/A
  • EPS
  • FFIC 0.87
  • FATE N/A
  • Revenue
  • FFIC $193,714,000.00
  • FATE $13,447,000.00
  • Revenue This Year
  • FFIC N/A
  • FATE N/A
  • Revenue Next Year
  • FFIC $11.28
  • FATE N/A
  • P/E Ratio
  • FFIC $19.90
  • FATE N/A
  • Revenue Growth
  • FFIC 4.54
  • FATE N/A
  • 52 Week Low
  • FFIC $10.74
  • FATE $1.96
  • 52 Week High
  • FFIC $18.40
  • FATE $8.83
  • Technical
  • Relative Strength Index (RSI)
  • FFIC 59.86
  • FATE 36.05
  • Support Level
  • FFIC $16.80
  • FATE $1.96
  • Resistance Level
  • FFIC $18.40
  • FATE $2.35
  • Average True Range (ATR)
  • FFIC 0.62
  • FATE 0.34
  • MACD
  • FFIC -0.06
  • FATE -0.01
  • Stochastic Oscillator
  • FFIC 73.37
  • FATE 7.14

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: